Mostrar el registro sencillo del ítem

dc.contributor.authorMartinez-Corral, Inés
dc.contributor.authorTrevaskis, Natalie L.
dc.contributor.authorGarcía-Caballero, Melissa
dc.date.accessioned2023-06-28T09:57:21Z
dc.date.available2023-06-28T09:57:21Z
dc.date.created2023-06-28
dc.date.issued2022-04-25
dc.identifier.citationMartinez-Corral I, Trevaskis NL and García-Caballero M (2022) Editorial: Modulating Vascular Lymphatic Growth in Disease: Current and Potential Pharmacological Approaches for Prevention and Treatment. Front. Pharmacol. 13:910142. doi: 10.3389/fphar.2022.910142es_ES
dc.identifier.urihttps://hdl.handle.net/10630/27104
dc.description.abstractThe lymphatic system is part of the circulatory system and it is indispensable for life. In physiological conditions, the main functions assigned to the lymphatic system are the maintenance of the interstitial fluid homeostasis, immune surveillance and the absorption of dietary fat in the intestine (Alitalo, 2011). However, morphological or functional changes in lymphatic vessels can contribute to disorders such as lymphedema, tumor metastasis, inflammation and other pathological conditions (Oliver et al., 2020). Therefore, there is an urgent need to further understand the mechanisms driving lymphatic dysfunction in these conditions and to develop novel lymph-targeted therapies. In this Research Topic, we present a collection of research articles that provide new insights into obesity-induced lymphatic dysfunction and tumor-draining lymph node reconstruction; and review articles that highlight and discuss the latest pharmacological approaches to treat lymphedema and mechanisms to target obesity and metabolic diseases through modulating lymphatic contraction.es_ES
dc.description.sponsorshiphis study was supported by the Beatriz Galindo Programme from the Spanish Ministry of Education and Professional Formation, Fundación Científica AECC (LABAE211691GARC) and the Instituto de Salud Carlos III (ISCIII) through the project “PI21/00653” and co-funded by the European Union (MG-C).es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.subjectSistema linfático - Enfermedadeses_ES
dc.subject.otherLymphaticses_ES
dc.subject.otherCanceres_ES
dc.subject.otherTreatmentes_ES
dc.subject.otherPharmacological approaches_ES
dc.titleModulating Vascular Lymphatic Growth in Disease: Current and Potential Pharmacological Approaches for Prevention and Treatmentes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.identifier.doidoi: 10.3389/fphar.2022.910142
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem